101 related articles for article (PubMed ID: 3315731)
1. Inhibition of hemoglobin degradation in Plasmodium falciparum by chloroquine and ammonium chloride.
Zhang Y
Exp Parasitol; 1987 Dec; 64(3):322-7. PubMed ID: 3315731
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of human malaria parasites to chloroquine is pH dependent.
Yayon A; Cabantchik ZI; Ginsburg H
Proc Natl Acad Sci U S A; 1985 May; 82(9):2784-8. PubMed ID: 3887411
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Famin O; Ginsburg H
Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
[TBL] [Abstract][Full Text] [Related]
4. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins.
Zhang Y; Hempelmann E
Biochem Pharmacol; 1987 Apr; 36(8):1267-73. PubMed ID: 3297071
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine.
Orjih AU; Ryerse JS; Fitch CD
Experientia; 1994 Jan; 50(1):34-9. PubMed ID: 8293798
[TBL] [Abstract][Full Text] [Related]
6. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
Zarchin S; Krugliak M; Ginsburg H
Biochem Pharmacol; 1986 Jul; 35(14):2435-42. PubMed ID: 3524576
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
Bray PG; Janneh O; Raynes KJ; Mungthin M; Ginsburg H; Ward SA
J Cell Biol; 1999 Apr; 145(2):363-76. PubMed ID: 10209030
[TBL] [Abstract][Full Text] [Related]
8. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of a protein tyrosine kinase activity in Plasmodium falciparum by chloroquine.
Sharma A; Mishra NC
Indian J Biochem Biophys; 1999 Oct; 36(5):299-304. PubMed ID: 10844978
[TBL] [Abstract][Full Text] [Related]
10. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
Famin O; Ginsburg H
Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
[TBL] [Abstract][Full Text] [Related]
11. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium.
Ginsburg H; Golenser J
Redox Rep; 2003; 8(5):276-9. PubMed ID: 14962364
[TBL] [Abstract][Full Text] [Related]
12. Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).
Callaghan PS; Hassett MR; Roepe PD
Biochemistry; 2015 Aug; 54(32):5083-94. PubMed ID: 26208441
[TBL] [Abstract][Full Text] [Related]
13. Role for the plasmodium falciparum digestive vacuole in chloroquine resistance.
Saliba KJ; Folb PI; Smith PJ
Biochem Pharmacol; 1998 Aug; 56(3):313-20. PubMed ID: 9744568
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus.
Li GD
Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
16. Isolation of chloroquine-resistant Chinese hamster V79 cell variants that are also resistant to ammonium chloride.
Ono M; Ando M; Shimada T; Furuno K; Kato K; Kuwano M
J Biochem; 1983 Nov; 94(5):1493-503. PubMed ID: 6654868
[TBL] [Abstract][Full Text] [Related]
17. Nucleus may be the key site of chloroquine antimalarial action and resistance development.
Li GD
Med Hypotheses; 2006; 67(2):323-6. PubMed ID: 16549276
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the effect of chloroquine and ammonium chloride on feeding process of Plasmodium falciparum in vitro.
Zhang Y; Just WW
Parasitol Res; 1987; 73(5):475-8. PubMed ID: 3309944
[No Abstract] [Full Text] [Related]
19. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
20. Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum.
Stocks PA; Raynes KJ; Bray PG; Park BK; O'Neill PM; Ward SA
J Med Chem; 2002 Nov; 45(23):4975-83. PubMed ID: 12408708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
